Skip to main content
. 2022 Mar 28;27(7):e580–e588. doi: 10.1093/oncolo/oyac053

Figure 3.

Figure 3.

Chord diagrams showing most common therapeutic subgroups (WHO ATC level 2 classification) involved in all potential drug-drug interactions (left) and potential major drug-drug interactions (right). Subgroup interactions with <20 (left) and <3 (right) occurrences are not shown.